Practical advice for avoidance of pain associated with insertion of intrauterine contraceptives

Luis Bahamondes, Diana Mansour, Christian Fiala, Andrew M Kaunitz, Kristina Gemzell-Danielsson, Luis Bahamondes, Diana Mansour, Christian Fiala, Andrew M Kaunitz, Kristina Gemzell-Danielsson

Abstract

Few studies in the scientific literature provide clear direction on the prevention or management of pain associated with intrauterine contraceptive (IUC) placement. Those that have been published have studied small numbers of women and fail to provide definitive conclusions. There are also no guidelines available detailing recognised standard approaches to this problem. The consensus recommendations in this review focus primarily on non-pharmacological and often non-evidence-based interventions. This review includes general considerations, practical recommendations for both routine and more difficult cases and guidance on the optimal choice of instruments. General considerations, including pre-insertion counselling, the setting for the procedure, the confidence and technique of the provider and the interplay between the provider and assistant, can influence women's level of anxiety and, in turn, influence their perception of pain and their overall experience. Further studies are required to refine the optimal strategy for managing pain associated with IUC insertion.

Keywords: family planning service provision; intrauterine devices.

Figures

Figure 1
Figure 1
Recommended instruments for performing intrauterine contraceptive placements. (A) Mini and standard tenacula. (B) Tapered versus parallel cervical dilators. (C) Dental syringe.

References

    1. Trussell J. Contraceptive failure in the United States. Contraception 2011;83:397–404
    1. Winner B, Peipert JF, Zhao Q, et al. Effectiveness of long-acting reversible contraception. N Engl J Med 2012;366:1998–2007
    1. Lyus R, Lohr P, Prager S. Use of the Mirena LNG-IUS and Paragard CuT380A intrauterine devices in nulliparous women. Contraception 2010;81:367–371
    1. National Institute for Health and Care Excellence. Clinical Knowledge Summaries UK Medical Eligibility Criteria for use of the levonorgestrel-releasing intrauterine system. 2011. [accessed 26 November 2012]
    1. National Institute for Health and Care Excellence. Clinical Knowledge Summaries UK Medical Eligibility Criteria for use of copper intrauterine devices. 2011. [accessed 26 November 2012]
    1. World Health Organization Medical Eligibility Criteria for Contraceptive Use (4th edn). 2010. [accessed 26 November 2012]
    1. Centers for Disease Control and Prevention MMWR Early Release: U.S. Medical Eligibility Criteria for Contraceptive Use, Vol. 59. 2010. [accessed 26 November 2012]
    1. ACOG Committee on Practice Bulletins-Gynecology Committee Opinion No. 539: Adolescents and long-acting reversible contraception: implants and intrauterine devices. Obstet Gynecol 2012;120:983–988
    1. Bahamondes MV, Hidalgo MM, Bahamondes L, et al. Ease of insertion and clinical performance of the levonorgestrel-releasing intrauterine system in nulligravidas. Contraception 2011;84:e11–e16
    1. Hubacher D, Reyes V, Lillo S, et al. Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofen. Am J Obstet Gynecol 2006;195:1272–1277
    1. Lassner KJ, Chen CH, Kropsch LA, et al. Comparative study of safety and efficacy of IUD insertions by physicians and nursing personnel in Brazil. Bull Pan Am Health Organ 1995;29:206–215
    1. Chi IC, Galich LF, Tauber PF, et al. Severe pain at interval IUD insertion: a case-control analysis of patient risk factors. Contraception 1986;34:483–495
    1. Brockmeyer A, Kishen M, Webb A. Experience of IUD/IUS insertions and clinical performance in nulliparous women–a pilot study. Eur J Contracept Reprod Health Care 2008;13:248–254
    1. Marions L, Lövkvist L, Taube A, et al. Use of the levonorgestrel releasing-intrauterine system in nulliparous women – a non-interventional study in Sweden. Eur J Contracept Reprod Health Care 2011;16:126–134
    1. Heikinheimo O, Inki P, Kunz M, et al. Double-blind, randomized, placebo-controlled study on the effect of misoprostol on ease of consecutive insertion of the levonorgestrel-releasing intrauterine system. Contraception 2010;81:481–486
    1. Allen RH, Bartz D, Grimes DA, et al. Interventions for pain with intrauterine device insertion. Cochrane Database Syst Rev 2009;. 3:CD007373.
    1. Fiala C, Gemzell-Danielsson K, Tang OS, et al. Cervical priming with misoprostol prior to transcervical procedures. Int J Gynaecol Obstet 2007;99(Suppl. 2):S168–S171
    1. Gemzell-Danielsson K, Mansour D, Fiala C, et al. Management of pain associated with the insertion of intrauterine contraceptives. Hum Reprod Update 2013;19:419–427
    1. Murty J. Use and effectiveness of oral analgesia when fitting an intrauterine device. J Fam Plann Reprod Health Care 2003;29:150–151
    1. Zhou L, Harrison-Woolrych M, Coulter DM. Use of the New Zealand Intensive Medicines Monitoring Programme to study the levonorgestrel-releasing intrauterine device (Mirena). Pharmacoepidemiol Drug Saf 2003;12:371–377
    1. Faúndes A, Alvarez F, Díaz J. A Latin American experience with levonorgestrel IUD. Ann Med 1993;25:149–153
    1. Sääv I, Aronsson A, Marions L, et al. Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial. Hum Reprod 2007;22:2647–2652
    1. Dijkhuizen K, Dekkers OM, Holleboom CA, et al. Vaginal misoprostol prior to insertion of an intrauterine device: an RCT. Hum Reprod 2011;26:323–329
    1. Gupta JK, Johnson N. Effect of mifepristone on dilatation of the pregnant and non-pregnant cervix. Lancet 1990;335: 1238–1240
    1. Faculty of Sexual and Reproductive Healthcare Clinical Effectiveness Unit FSRH Guidance (Nov 2007) Intrauterine Contraception. 2007. [accessed 14 March 2013]
    1. Maguire K, Davis A, Rosario Tejeda L, et al. Intracervical lidocaine gel for intrauterine device insertion: a randomized clinical trial. Contraception 2012;86:214–219
    1. McNicholas CP, Madden T, Zhao Q, et al. Cervical lidocaine for IUD insertion pain: a randomized controlled trial. Am J Obstet Gynecol 2012;207:384.e1.–e
    1. Nadelberg R. Paracervical Block. Boston Scientific Corporation. 2007. [accessed 26 November 2012]

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner